Gestapuran
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
219 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Contraception | D003267 | — | — | 14 | 4 | 1 | 12 | 18 | 46 |
| Endometrial neoplasms | D016889 | EFO_0004230 | — | — | 13 | 4 | 1 | 4 | 20 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 3 | 3 | — | 2 | 8 | 16 |
| Hemorrhage | D006470 | MP_0001914 | R58 | 1 | 1 | 4 | 2 | 5 | 12 |
| Uterine hemorrhage | D014592 | — | — | 1 | 1 | 3 | 2 | 4 | 10 |
| Postmenopause | D017698 | — | — | 3 | 1 | 4 | 1 | 1 | 10 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | 2 | 4 | 2 | 2 | 9 |
| Infertility | D007246 | EFO_0000545 | — | — | — | 2 | 3 | 3 | 8 |
| Endometrial hyperplasia | D004714 | — | N85.0 | 1 | 5 | 2 | 2 | — | 8 |
| Hyperplasia | D006965 | EFO_0000536 | — | 1 | 5 | 2 | 2 | — | 8 |
Show 33 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Endometrioid carcinoma | D018269 | — | — | 1 | 3 | 1 | — | 3 | 7 |
| Syndrome | D013577 | — | — | — | 1 | 1 | — | 4 | 6 |
| Menorrhagia | D008595 | EFO_0003945 | N92.0 | — | — | 4 | — | 2 | 6 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 1 | 6 | — | — | 6 |
| Carcinoma | D002277 | — | C80.0 | — | 4 | 1 | — | — | 5 |
| Coronary disease | D003327 | — | — | — | 1 | 5 | — | — | 5 |
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | 1 | 5 | — | — | 5 |
| Menopause | D008593 | EFO_0003922 | N95 | — | 2 | 2 | — | — | 4 |
| Healthy volunteers/patients | — | — | — | 3 | 1 | 1 | — | — | 4 |
| Adenocarcinoma | D000230 | — | — | 1 | 2 | 1 | — | — | 4 |
Show 29 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | — | 1 | — | — | 2 | 3 |
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | 1 | — | — | — | 1 |
| Prehypertension | D058246 | — | — | — | 1 | — | — | — | 1 |
| Persistent fetal circulation syndrome | D010547 | EFO_1001103 | P29.3 | — | 1 | — | — | — | 1 |
| Recurrence | D012008 | — | — | — | 1 | — | — | — | 1 |
| Adenosquamous carcinoma | D018196 | — | — | — | 1 | — | — | — | 1 |
| Myelodysplastic syndromes | D009190 | — | D46 | — | 1 | — | — | — | 1 |
| Preleukemia | D011289 | — | — | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Contraception behavior | D003268 | — | — | 1 | — | — | — | 4 | 5 |
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | 2 | — | — | — | 1 | 3 |
| Emergencies | D004630 | — | — | 1 | — | — | — | 1 | 2 |
| Postcoital contraception | D044363 | — | — | 1 | — | — | — | 1 | 2 |
| Kidney transplantation | D016030 | — | — | 1 | — | — | — | — | 1 |
| Immunosuppression therapy | D007165 | — | — | 1 | — | — | — | — | 1 |
| Pregnancy rate | D018873 | — | — | 1 | — | — | — | — | 1 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | — | — | — | — | 1 |
| Estrogen replacement therapy | D015914 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Body weight | D001835 | EFO_0004338 | — | — | — | — | — | 3 | 3 |
| Fertility | D005298 | — | — | — | — | — | — | 2 | 2 |
| Tissue adhesions | D000267 | — | — | — | — | — | — | 2 | 2 |
| Body weight changes | D001836 | — | — | — | — | — | — | 2 | 2 |
| Weight loss | D015431 | — | — | — | — | — | — | 2 | 2 |
| Infections | D007239 | EFO_0000544 | — | — | — | — | — | 2 | 2 |
| Communicable diseases | D003141 | — | — | — | — | — | — | 2 | 2 |
| Fertility preservation | D059247 | — | — | — | — | — | — | 2 | 2 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
| Premenstrual dysphoric disorder | D065446 | — | F32.81 | — | — | — | — | 1 | 1 |
Show 39 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use